Varex Imaging (VREX) Stock: Buy, Sell, or Hold?
VREX - Varex Imaging Corporation Common Stock
$18.41
-0.01 (-0.05%)
▼
5d:
-0.32%
30d:
-0.22%
90d:
+68.59%
HOLD
MODERATE Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 17, 2026
24d
Get Alerted When VREX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VREX trades at premium valuation expecting 9.9% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: VREX trades at premium valuation expecting 9.9% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.09
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.82
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VREX is currently trading at $18.41, which is considered oversold relative to its 30-day fair value range of $18.42 to $18.49. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.2) compared to its historical average (13.0). At these levels, the market is pricing in 9.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VREX is in a strong uptrend. The price is currently testing key support at $18.35. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VREX is in a strong uptrend. The price is currently testing key support at $18.35. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.42 -
$18.49
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($18.90)
- NEUTRAL: PE elevated vs history but 9.9% growth expectation is conservative given 453% recent growth
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$18.42 -
$18.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.35
Resistance Level
$18.49
Current Trend
Strong Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.21
Wall Street Target
$18.90
(+2.7%)
Revenue Growth (YoY)
3.7%
Earnings Growth (YoY)
453.4%
Profit Margin
2.6%
Valuation Premium vs History
+9.9% premium
PE vs Historical
17.2 vs 13.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.9%
(market-implied from PE analysis)
1-Year Target
$20.23
(+10%)
2-Year Target
$22.24
(+21%)
3-Year Target
$24.44
(+33%)
3-Yr Target (if PE normalizes)
(PE: 17→13)
PE COMPRESSION
$18.46
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 27.4%)
$43.92
(+139%)
Base:
(SPY PE: 17.2, Growth: 27.4%)
$38.05
(+107%)
Bear:
(PE: 13.0, Growth: 27.4%)
$28.75
(+56%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 34.75 | Current EPS (TTM): $0.53
Bull Case
$40.52
(+120%)
Analyst growth 100.0%, PE expands to 38.2
Base Case
$36.84
(+100%)
Market implied 100.0%, PE stable at 34.8
Bear Case
$12.53
(-32%)
Severe decline -20.0%, PE contracts to 29.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 2:15 AM ET
Data refreshes hourly during market hours. Next update: 3:15 AM
Data refreshes hourly during market hours. Next update: 3:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VREX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 45 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 51 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 32 SELL |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
15 analysts |
$171 | 48 HOLD |
